GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kane Biotech Inc (TSXV:KNE) » Definitions » Total Long-Term Liabilities

Kane Biotech (TSXV:KNE) Total Long-Term Liabilities : C$1.59 Mil (As of Mar. 2025)


View and export this data going back to 2003. Start your Free Trial

What is Kane Biotech Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. Kane Biotech's Total Long-Term Liabilities for the quarter that ended in Mar. 2025 was C$1.59 Mil.

Kane Biotech Total Long-Term Liabilities Historical Data

The historical data trend for Kane Biotech's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kane Biotech Total Long-Term Liabilities Chart

Kane Biotech Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.04 2.98 3.42 3.20 1.71

Kane Biotech Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Total Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.02 1.95 1.83 1.71 1.59

Kane Biotech Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.

Kane Biotech Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Kane Biotech's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Kane Biotech Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kane Biotech Inc (TSXV:KNE) » Definitions » Total Long-Term Liabilities
Comparable Companies
XCNQ:GLOW TSXV:RKV TSXV:IBO TSXV:CYTO XCNQ:BIOV TSX:APS TSXV:QPT TSXV:IOT XCNQ:ASEP XCNQ:BLAB VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
KNBIF:USA
Address
290-100 Innovation Drive, Winnipeg, MB, CAN, R3T 6G2
Website
https://www.kanebiotech.com
Kane Biotech Inc is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The company has a portfolio of biotechnologies, intellectual property and products developed by its own biofilm research expertise and acquired from research institutions. The company's operating segments are animal health and human health. It derives maximum revenue from Animal health segment.
Executives
Marc Edwards Director
Philip Renaud Director
Raymond David Eugene Dupuis Senior Officer
Richard J. Renaud 10% Security Holder
Georges Morin Director
Rashieda Gluck Director

Kane Biotech Headlines

No Headlines